Last reviewed · How we verify
Oxycodone 60 mg — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Oxycodone 60 mg (Oxycodone 60 mg) — BioDelivery Sciences International.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Oxycodone 60 mg TARGET | Oxycodone 60 mg | BioDelivery Sciences International | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Oxycodone 60 mg CI watch — RSS
- Oxycodone 60 mg CI watch — Atom
- Oxycodone 60 mg CI watch — JSON
- Oxycodone 60 mg alone — RSS
Cite this brief
Drug Landscape (2026). Oxycodone 60 mg — Competitive Intelligence Brief. https://druglandscape.com/ci/oxycodone-60-mg. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab